When No Specimen Exists: A Pre-Analytic Blind Spot in Pediatric Care

The vast body of literature on pre-analytic laboratory errors focuses predominantly on the quality and integrity of specimens that have already been collected. But a critical failure mode is systematically overlooked: the complete inability to obtain a specimen, a scenario we term "access failure." This blind spot is most acutely exposed in pediatric care, where patient distress, neurodivergence, and prior trauma create significant barriers to collection.

The current paradigm, which defaults to training as a solution for human factor-related errors, is insufficient. Instead, a focus on "pre-analytic readiness"—the emotional, sensory, and environmental conditions that precede collection—is required. By safely exploring this access gap through descriptive, non-interventional feasibility studies, the healthcare system can address a foundational barrier to diagnostic innovation and improve patient care. 

The overlooked failure mode

It is well-established that the pre-analytical phase is the most vulnerable part of the total testing process, accounting for up to 70 percent of all laboratory errors.1 Decades of research and quality improvement initiatives have focused on mitigating these errors, with extensive literature dedicated to issues of specimen quality such as hemolysis, clotting, contamination, and improper labeling.

While critical, this focus presupposes a fundamental starting point: that a specimen has been successfully collected. A significant blind spot in the literature and in practice is the scenario where no specimen is obtained at all. This "access failure" represents a total and immediate dead end in the diagnostic pathway, yet it receives remarkably little attention compared to the downstream issues of specimen integrity.

Why pediatrics exposes the gap

Nowhere is the problem of failure to obtain a specimen more visible than in pediatric care. While an adult may experience anxiety or discomfort during a blood draw, a child’s response can become a fundamental barrier to the procedure itself. Extreme distress, needle phobia, prior medical trauma, and the unique sensory needs of neurodivergent populations can make venipuncture not just difficult, but impossible.  

In these scenarios, repeated attempts can escalate the situation, leading to a caregiver’s refusal to continue. This is not a matter of non-compliance; it is a hard stop in the care process. Outpatient settings, where the controlled environment of a hospital is absent, further amplify these challenges, making pediatric populations the clearest indicator of this systemic gap.

Why training alone hasn’t solved this

The literature on pre-analytical errors consistently identifies "human factors" as the root cause. However, the proposed solutions almost invariably default to more education, training, and stricter adherence to protocols. This approach may underestimate the systemic nature of the problem. If decades of training have not fully resolved the issue, it suggests that system design, not personnel effort, deserves closer examination. The persistence of high error and rejection rates is a clear reflection of this mismatch. The challenge in pediatric access is not a knowledge gap to be filled by training, but a complex interplay of environmental, psychological, and physiological factors that require a system redesign.

The cost of “No Specimen”

The consequences of failure to obtain a specimen extend far beyond the inconvenience of a missed test. When no specimen can be obtained, the clinical and systemic costs multiply. The most immediate impact is a delayed or missed diagnosis, leaving clinicians without the information needed to guide treatment. This often necessitates repeat visits, consuming caregiver time and resources while increasing the burden on the healthcare system.

Furthermore, the experience itself can be deeply damaging. Escalating distress can lead to the use of physical restraint, a practice that can inflict lasting psychological trauma. This erodes caregiver trust in the healthcare system and can lead to future avoidance of necessary medical care. For healthcare staff, these encounters contribute significantly to moral distress and burnout.

Pre-analytic readiness: A new concept

Pre-analytic readiness refers to the conditions that determine whether collection is feasible before technical skill becomes relevant. To truly address access failure, we must introduce the concept of "pre-analytic readiness." This state exists before the needle is ever uncapped. It encompasses the holistic conditions that determine the feasibility of a successful collection. Key components of pre-analytic readiness include: 

• Emotional Readiness: Is the patient in a state of calm or escalating distress?
• Sensory Readiness: Is the environment (lighting, noise, temperature) optimized to prevent sensory overload, particularly for neurodivergent individuals?
• Cognitive Readiness: Does the patient and caregiver understand the procedure? Have they been given choices and a sense of control?

Focusing on readiness shifts the paradigm from forcing compliance to creating the conditions for successful cooperation.

Why this matters for diagnostic innovation

The promise of new diagnostic technologies—less invasive devices, assays requiring smaller sample volumes—can only be realized if a specimen can be obtained in the first place. A company can develop a revolutionary device, but if it cannot be successfully deployed with an anxious child in a busy clinic, its impact will be limited. The primary barriers to adoption for these innovations are often human, not technical. By ignoring the problem of access, we are placing a ceiling on the potential impact of diagnostic innovation.

What can be explored safely

Addressing this blind spot does not require high-risk clinical trials. The path forward lies in descriptive, feasibility-oriented observation. By framing studies as non-interventional explorations of workflow and human factors, we can gather invaluable data within a regulatory-safe context. These studies would make no clinical claims, draw no diagnostic comparisons, and would not replace the standard of care. Instead, they would focus on answering a simple question: In scenarios where we currently fail to get a specimen, what conditions enable success? This approach allows for ethical, low-risk learning that can inform the design of better systems, training programs, and technologies.

Look forward to improve

To truly improve diagnostic medicine, we must look upstream of the analyzer. The quality of a specimen is irrelevant if the specimen itself does not exist. Access must come before analysis. The unique challenges of pediatric care do not represent an exception to the rule; rather, they make a broader blind spot in the pre-analytic phase impossible to ignore. By focusing on pre-analytic readiness and embracing descriptive, feasibility-focused studies, we can begin to solve the foundational problem of access and unlock the full potential of diagnostic innovation for all patients.

Reference

1. Getawa S, Aynalem M, Melku M, Adane T. Blood specimen rejection rate in clinical laboratory: A systematic review and meta-analysis. Pract Lab Med. 2022;28:e00288. doi:10.1016/j.plabm.2022.e00288